Retinoid Therapy for Rheumatoid Arthritis
- EDWARD D. HARRIS, JR., M.D.
- University of Medicine and Dentistry of New Jersey-Rutgers Medical School; New Brunswick, New Jersey
Excerpt
Effective therapeutic intervention in the course of rheumatoid arthritis often involves using more than one class of drugs. This use of polypharmacologic therapy is not surprising considering the complex pathophysiologic process of the disease. In rheumatoid arthritis, acute inflammation, manifested by large numbers of polymorphonuclear leukocytes in the synovial fluid and activation of the clotting, kinin, and fibrinolytic systems, is matched both by chronic inflammation involving macrophages and lymphocytes in the synovium and by enormous proliferation of synovial cells capable of generating enzymes that destroy cartilage, tendon, and bone. Indeed, because of the aggressive manner in which it destroys joints,
This 100-word excerpt has been provided in the absence of an abstract.
Acknowledgments
The author thanks Linda Newman for preparation of the manuscript.
Article and Author Information
-
Grant support: in part by grant AM 14780 by the U.S. Public Health Service.
RSS Feeds









